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Post-translational  protein  modiﬁcations  initiate,  regulate,  propagate  and  terminate  a  wide  variety  of
processes  in cells,  and in  particular,  ubiquitylation  targets  substrate  proteins  for  degradation,  subcellular
translocation,  cell signaling  and  multiple  other  cellular  events.  Modiﬁcation  of substrate  proteins  is widely
observed  to occur  via  covalent  linkages  of ubiquitin  to the  amine  groups  of lysine  side-chains.  However,
in  recent  years  several  new  modes  of  ubiquitin  chain  attachment  have  emerged.  For  instance,  covalent
modiﬁcation  of  non-lysine  sites  in substrate  proteins  is theoretically  possible  according  to basic  chemicalon-canonical ubiquitylation
biquitin
rotein  degradation
biquitinomics
biquitin ligase
principles  underlying  the  ubiquitylation  process,  and  evidence  is  building  that  sites  such as  the  N-terminal
amine  group  of a protein,  the hydroxyl  group  of  serine  and  threonine  residues  and  even the thiol  groups
of  cysteine  residues  are  all employed  as sites  of  ubiquitylation.  However,  the  potential  importance  of
this  “non-canonical  ubiquitylation”  of  substrate  proteins  on  sites  other  than  lysine  residues  has  been
largely  overlooked.  This review  aims  to highlight  the  unusual  features  of  the  process  of  non-canonical
ubiquitylation  and  the consequences  of these  events  on the  activity  and  fate  of a protein.© 2013 The Authors. Published by Elsevier Ltd. 
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Open access under CC BY license.1. Mechanisms of ubiquitylation
Ubiquitylation,  the speciﬁc addition of ubiquitin groups to tar-
geted proteins, regulates processes as diverse as proteasomal and
lysosomal degradation, subcellular localization and DNA  damage
repair (Kerscher et al., 2006). Of these, our fullest understanding
comes from many years of biochemical investigation of the degra-
dation of ubiquitylated proteins by the proteasome (reviewed in
(Hershko and Ciechanover, 1998; Varshavsky, 1997b), see Fig. 1).
The process of ubiquitylation begins with the adenylation of
the C-terminus of ubiquitin (Ub), an 8.5 kDa, 76-residue protein,
by the Ub-activating (E1) enzyme using energy from the hydrol-
ysis of ATP (Hershko et al., 1981). This modiﬁcation activates the
1834 G.S. McDowell, A. Philpott / The International Journal of Biochemistry & Cell Biology 45 (2013) 1833– 1842
Fig. 1. The ubiquitylation cascade. Ub is activated by an Ub-activating (E1) enzyme using energy from ATP hydrolysis and passed to an Ub-conjugating (E2) enzyme. Ub
can  then be passed to a substrate protein, speciﬁed by the distinct E3 ligase that binds both the substrate and the E2. Many E3 ligases, such as the Really Interesting New
Gene (RING) E3 ligases, act as a scaffold to pass Ub from the E2 directly to the substrate protein. In contrast, HECT (homologous to E6-AP carboxy-terminus) E3 ligases form
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rocesses. Ubs can be cleaved from the protein at all stages by the action of de-ubiq
b moiety energetically throughout the ubiquitylation cascade for
ventual transfer to the substrate protein. Ub is then covalently
used via a thioester linkage to a cysteine residue in the E1 by
ttack of the cysteine at the C-terminus of ubiquitin, releasing AMP
Ciechanover et al., 1981). The E1 cannot just take Ub straight to
he substrate (though such a concept is possible, such as in non-
ibosomal polypeptide synthesis (Cane and Walsh, 1999)). Instead,
b is shuttled from the E1 onto a cysteine residue of an Ub-
onjugating (E2) enzyme (Hershko et al., 1983), of which there are
t least 50 in the mammalian genome (Wu et al., 2003). This E2 can
hen pass on this Ub moiety to protein targets in concert with an
b (E3) ligase.
Ubiquitylation may  involve the E2 passing the Ub directly onto
he substrate protein using the E3 ligase as a scaffold, such as with
he Skp-Cullin-F-box (SCF) class of E3 ligase (Jackson et al., 2000).
lternatively, the E2 passes the ubiquitin to a cysteine residue of
 homologous to the E6-AP carboxyl terminus (HECT) E3 ligase,
hich then passes the ubiquitin to its protein target (Huibregtserotein, is then itself ubiquitylated by either successive rounds of ubiquitylation or
ylated to the appropriate extent, the substrate is targeted for a variety of cellular
ting enzymes (DUBs).
et  al., 1995). In either case, the Ub is “canonically” passed onto
a lysine residue of the substrate protein via an isopeptide bond.
The cycle can then be repeated to add further Ub moieties to the
Ub already attached to the substrate. In some cases, E4 ligases can
add a polyUb chain to a monoubiquitylated site: for instance p300
can carry out this function on a site monoubiquitylated by Mdm2
on p53 (Grossman et al., 2003). It is, however, the E3 ligase that
confers speciﬁcity for the ﬁnal ubiquitylation of the substrate pro-
tein (Hershko, 1988) and this class of enzymes show the greatest
diversity within the ubiquitylation machinery, numbering several
hundred in mammals (Huibregtse et al., 1995; Jackson et al., 2000;
King et al., 1995; Sudakin et al., 1995).
The particular site of ubiquitin chain linkage between Ub
molecules can be determined either by the E2 alone (David et al.,
2010) or in some cases more speciﬁcally by the E3 ligase (David
et al., 2011). Various linkages of polyUb chains may confer dis-
tinct properties. For example, K48-linked chains target proteins for
proteasomal degradation (Thrower et al., 2000) as can K11-linked
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hains (Matsumoto et al., 2010; Song and Rape, 2011), while in fact
xperimentally, it has been shown that all lysines except K63 are
ble to target proteins for proteasomal degradation (Xu et al., 2009).
everal other Ub chain linkages have been described, and these can
ave a variety of other biological functions such as regulating sub-
ellular localization (Pickart and Fushman, 2004), as described in
igure 1. Indeed, it is clear that many other combinations of homol-
gous, heterologous and branched ubiquitin chains are possible and
he functions of these are yet to be elucidated (Komander, 2009).
.  Canonical ubiquitylation
Canonical  ubiquitylation sites on target proteins are described
s lysine residues in the deﬁnition of the ubiquitin proteasome sys-
em (UPS) described above (Freiman and Tjian, 2003). However,
nlike many post-translational modiﬁcations, and even unlike Ub-
ike modiﬁers such as small Ub-like modiﬁer (SUMO), there is no
nown consensus site for identifying an ubiquitylation site (Peng
t al., 2003), although there are examples of protein ubiquitylation
ccurring on speciﬁed lysines, such as lysines 21 and 22 in IB
Baldi et al., 1996). Conversely there are proteins where ubiquity-
ation can occur on any lysine, for example c-Jun (Treier et al., 1994)
nd cyclin B (King et al., 1996). Therefore determination of which
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ig. 2. Nucleophilic sites of ubiquitylation. Proteins contain many nucleophilic sites cap
est-described sites are (A) the amine-containing internal lysine residues and the free a
nd  (C) hydroxyls on serines, threonines and tyrosines could also potentially be ubiquityliochemistry & Cell Biology 45 (2013) 1833– 1842 1835
lysine  residues in a protein are ubiquitylated must be undertaken
on a case-by-case basis.
If  the canonical description of ubiquitylation is correct (Freiman
and Tjian, 2003), removal of all lysine residues in a protein should
completely stabilize against Ub-mediated proteasomal degrada-
tion. Indeed there are examples of proteins that appear completely
stabilized by removal of lysines, most commonly by mutation of
lysines to arginines or by chemical lysine modiﬁcation (Hershko
et al., 1986). However many investigators observed that proteins
lacking lysines were still being polyubiquitylated and that these
polyUb chains could still target the substrate protein for proteaso-
mal degradation. Where could this ubiquitylation be occurring?
3.  Ubiquitin isopeptide linkages to lysines and peptide
linkages to the N-terminus
Lysine  residues form a covalent linkage to Ub by formation of
an isopeptide bond to the carboxy terminus of Ub using the lysine
amine group (see Fig. 2A). Lysine-less proteins are missing these
side-chains but all proteins contain another amine group; polypep-
tides consist of a backbone created by peptide bond formation
between amino acid residues, so in a linear chain there is always a
free amine group (at the N-terminus) and a free carboxylate group
SHE2
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able of attacking an E2-Ub thioester linkage and undergoing ubiquitylation. The
mine of the N-terminus of the polypeptide backbone. However (B) cysteine thiols
ated by an identical mechanism.
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at the C-terminus). Thus, the N-terminus presents a reactive amine
roup that could be fused to Ub in the same way as lysine. Such N-
erminal ubiquitylation was ﬁrst identiﬁed in MyoD (Breitschopf
t al., 1998). Preventing ubiquitylation of all amine groups by reduc-
ive dimethylation, and of the N-terminal amine group of MyoD
peciﬁcally by carbamylation (Hershko et al., 1984) not only sta-
ilized the protein, but also demonstrated that MyoD lysines are
ot ubiquitylated when the N-terminal amine group is blocked.
ence, N-terminal ubiquitylation may  be required as a ‘priming’
biquitylation (Breitschopf et al., 1998).
It is important to note that ubiquitylation of the N-terminal
mine group itself is distinct from ubiquitylation by the ‘N-end rule’
Wang et al., 2008, reviewed in Varshavsky, 2011). A destabiliz-
ng N-terminal residue in a protein can act as a degron to facilitate
biquitylation and proteasomal degradation. However the Ub moi-
ty in N-end rule-targeted ubiquitylation is fused to an internal
ysine residue and not to the N-terminal amine group. Therefore
he N-terminus acts as a signal but not as an acceptor for ubiquity-
ation.
To check that N-terminal amine ubiquitylation was truly
esponsible for destabilizing MyoD (rather than representing tar-
eting via the N-end rule), a number of other possible processes
ere also investigated. Conversion of the N-terminal residue of
yoD into a lysine residue (as occurs with conversion of some
cidic residues to arginine to target for ubiquitylation via the N-end
ule (Ferber and Ciechanover, 1987)) did not occur and so does not
ccount for the destabilizing effect of the N-terminal residue. More-
ver, the effects of the N-end rule on non-canonical ubiquitylation
f MyoD were dismissed as N-end rule inhibitors had no effect on
he stability of MyoD (Breitschopf et al., 1998). Fusion of a Myc-
ag to the N-terminus to block the ubiquitylation of the N-terminal
mine of MyoD did stabilize the protein (Breitschopf et al., 1998)
although we would note that a C-terminal fusion control was  not
ttempted, see below). Overall the evidence clearly indicates that
-terminal amine ubiquitylation, and not the N-end rule, targets
yoD for proteasomal degradation.
N-terminal ubiquitylation is apparent in a number of proteins
Breitschopf et al., 1998; Chen et al., 2004; Ciechanover and Ben-
aadon, 2004; Kuo et al., 2004; Mayer, 2005; Sadeh et al., 2008); for
nstance recent evidence has shown a role in cell cycle-regulating
roteins such as cyclin G1 (Li et al., 2009). It has also been demon-
trated that there are naturally occurring lysineless proteins such
s p16INK4a and HPV-58 E7 where this non-canonical N-terminal
biquitylation must be essential for UPS-mediated degradation
Ben-Saadon et al., 2004). In addition, the Ub fusion degradation
UFD) pathway can target proteins for degradation where Ub is
used linearly via its C-terminus to the N-terminus of a protein
Johnson et al., 1995).
The  most direct veriﬁcation of N-terminal ubiquitylation would
e by mass spectrometry (MS) and this technique has been
sed to demonstrate N-terminal ubiquitylation of ERK3 and p21
Coulombe et al., 2004). However, mass spectrometry may  not
lways be suitable for such analysis if the N-terminus does not yield
 suitably-sized peptide, or if the peptide is too unstable to reach
andem MS  analysis. In lieu of MS  evidence, biochemical analyses
re required.
Deletion of a portion of the N-terminus, for example the ﬁrst
0 residues, could demonstrate the importance of the N-terminus
n targeting the substrate for polyubiquitylation. However this
ay not allow distinction of N-terminal ubiquitylation from
biquitylation targeted by the N-end Rule (Varshavsky, 1997a);
oth may  require a particular sequence at the N-terminus to target
or ubiquitylation but the modiﬁcation will occur at different sites
n the two processes. Moreover, an obvious caveat to this approach
s that there is still a free amine group at the truncated N-terminus.
herefore preventing ubiquitylation of the N-terminus of a proteiniochemistry & Cell Biology 45 (2013) 1833– 1842
more  directly is necessary to unequivocally demonstrate native
N-terminal ubiquitylation.
A  common strategy is to add a bulky tag to the N-terminus
of the protein (Trausch-Azar et al., 2010) under the rationale that
such a group will physically block the normal N-terminal site from
ubiquitylation. In many cases this does seem to result in protein sta-
bilization, but there are many factors to consider when designing
such an approach. Firstly, there is some debate as to what deﬁnes
a “bulky” tag (Trausch-Azar et al., 2010). Secondly, once a tag is
established as suitable and stabilizes the protein when fused to the
N-terminus, it is important to determine that fusion of the same
tag to the C-terminus does not also bring about protein stabiliza-
tion; this control is often not included but can be very informative
(Vosper et al., 2009). Moreover, in the case of intrinsically disor-
dered proteins it may  well be the case that a tag, particularly a
folded tag such as GFP, may  stabilize the protein through blockage
of unfolding initiation sites also required for proteasomal degra-
dation (Prakash et al., 2004). This was  the case with the proneural
protein Ngn2 (Vosper et al., 2009), where N-terminal fusion of GFP
stabilizes Ngn2, but so does the C-terminal fusion.
A third approach for identifying N-terminal ubiquitylation could
be by using chemical methods to “block” the N-terminus i.e. directly
preventing its ubiquitylation. Methods to prevent ubiquitylation
include reductive methylation with sodium cyanoborohydride,
guanidination with O-methylisourea or carbamylation (Breitschopf
et al., 1998). Due to similarity of the lysine and N-terminal amine
groups, reductive methylation will also result in blocking of all
lysine residue side-chains as well as the N-terminus. However
guanidination is speciﬁc to lysine residues whilst carbamylation
is speciﬁc to the N-terminal amine group only.
There is also a fourth method to speciﬁcally block the N-
terminus alone. Particular amino acid residues at the N-terminus
are associated with up- or down-regulation of co-translational
N-terminal acetylation (Bradshaw et al., 1998; Polevoda and
Sherman, 2000, 2003a,b). It has been suggested that N-terminal
co-translational acetylation occurs in 75% of eukaryotic pro-
teins (Polevoda and Sherman, 2003b) although an investigation
of N-terminal processing disputes this and places the ﬁgure at
30% (Meinnel et al., 2005). Notwithstanding, the process of N-
terminal acetylation is well characterized, including identiﬁcation
of N-terminal consensus sites for the regulation of acetylation
(Bradshaw et al., 1998; Polevoda and Sherman, 2002, 2003a,b;
Utsumi et al., 2001), and studies of protein degradation in N-
terminally acetylated proteins have been undertaken (Polevoda
and Sherman, 2002). Importantly, N-terminal co-translational acet-
ylation has been shown to be incompatible with N-terminal
ubiquitylation (Caron et al., 2005). The speciﬁcity of the effect of
N-terminal acetylation on preventing ubiquitylation, and hence
UPS-mediated degradation, can be veriﬁed by blocking acetylation
using the Palmiter method (Palmiter, 1977). Using this method
Vosper and colleagues found that Ngn2 is targeted for degradation
by N-terminal ubiquitylation (Vosper et al., 2009).
4. Ubiquitylation on additional non-canonical sites
As  an additional site for ubiquitylation to the established lysines,
the N-terminal amine group still resembles them chemically, but it
is possible to generalize the mechanism of ubiquitylation further.
Lysines are able to form isopeptide bonds due to the presence of a
nitrogen atom that can attack the thioester linkage between ubi-
quitin and the ubiquitin-conjugating (E2) enzyme. In this manner
the nitrogen is acting as a nucleophile, attracted to electropositive
centers by virtue of its lone pair of electrons, and this can attack the
thioester linkage at the electron-deﬁcient carbonyl carbon, which
acts therefore as an electrophile. In principle, the same mechanism
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ight be employed but using other nucleophiles aside from nitro-
en. There are several amino acid residues with the potential to
ttack electron-deﬁcient carbonyl carbons as nucleophiles; serines,
hreonines and tyrosines all contain electron-rich oxygen atoms
apable of forming hydroxyester bonds, while cysteine residues
ave the potential to act as nucleophiles using lone pairs of elec-
rons on sulfur (illustrated in Fig. 2). Two key questions must be
sked with respect to these types of non-canonical ubiquitylation:
oes it occur; and is it physiologically relevant?
. Thioester linkage of ubiquitin to cysteine
That cysteine residues might undergo modiﬁcation by ubiqui-
ylation may  seem at ﬁrst counterintuitive as thioester linkages (in
 manner similar to disulphide bonds) can be broken under reduc-
ng conditions and the intracellular environment is often viewed
s “reducing”. However, as described above and in Fig. 1, at each
tage of the ubiquitylation process, before loading ubiquitin onto
he substrate the E1/2/3 enzymes are all able to carry ubiquitin via
 thioester linkage, which is used to allow energetically favorable
ttack of the substrate nucleophile. The stability of these E1/2/3
ntermediates was recently discussed (Song et al., 2009). The reac-
ivity of E2/3 thiol residues and thioester bonds is affected by
he E2 and E3 enzymes, mainly by non-covalent protein–protein
nteractions. In fact, the Ub–cysteine interaction is so stable, it has
een suggested that thioesterases may  be required to control any
nwanted cysteine ubiquitylation on E2 and E3 enzymes (Song
t al., 2009). Indeed, exposed cysteine residues on the surface of
roteins have the closest pKa to physiological pH of any amino
cid residue and so very small changes in pH can control their
ucleophilicity greatly (Marino and Gladyshev, 2011), making them
otential sites for ubiquitylation of multiple proteins.
A  role for cysteine ubiquitylation was ﬁrst identiﬁed in the
eroxisomal import factor Pxp5 where this modiﬁcation plays
 signaling role (Carvalho et al., 2007; Grou et al., 2008; Kragt
t al., 2005; Leon and Subramani, 2007; Williams et al., 2007).
ysineless Pxp5 was still ubiquitylated whilst ubiquitylation of the
-terminal amine group was prevented by co-translational acet-
lation as shown by mass spectrometry (Williams et al., 2007).
able 1
on-canonically ubiquitylated proteins. NT: N-terminus; C: cysteine; S: serine; T: threon
Protein Function Non-canonical site Notab
MyoD Transcription factor NT N-ter
ubiqu
Erk3  Cell cycle – kinase NT Direc
p21  Cell cycle – cyclin dependent
kinase  inhibitor
NT 
HPV16 E7 Viral protein NT 
EBV  LMP1 Viral protein NT 
EBV  LMP2A Viral protein NT 
Id2  Transcriptional regulation NT 
ARF  p53 antagonist – tumor
suppressor
NT  No lys
mous
Pex5p  Protein translocation C Mono
Pex20p  Protein targeting and
translocation
C  For re
ubiqu
TCR  Immunity S ERAD
NS-1  Immunoglobulin S, T pH de
BST-2/tetherin Antiviral restriction factor C, S, T HIV V
ubiqu
CD4  Immunity C, S, T HIV V
ubiqu
Bid Apoptosis C, S, T Prote
MHCI  Immunity C, S, T Recog
Sarco
degra
Ngn2  Transcription factor NT, C, S, T Verte
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Ubiquitylation  on cysteines was  postulated and such a possibility
was investigated by comparing SDS-PAGE in reducing and non-
reducing conditions (Carvalho et al., 2007) (as the thioester linkage
is broken by the presence of reducing agents). This approach did
indeed demonstrate that reducing agent-dependent ubiquityla-
tion of Pxp5 occurred on a conserved cysteine residue (Williams
et al., 2007). The related protein Pex20p also undergoes cysteine
ubiquitylation to recycle the protein to the cytosol from the per-
oxisome (Leon and Subramani, 2007). In all other conﬁrmed cases
of non-canonical ubiquitylation, the modiﬁed protein is targeted
for degradation, (see Table 1). Overall, many more non-canonical
ubiquitylation events and their functions will have to be elucidated
before we  can conclude that ubiquitylation predominantly controls
protein stability or whether it has a wider role in cellular signaling.
This cysteine monoubiquitylation on Pxp5 could be considered
a transient modiﬁcation in which a weak thioester linkage might
provide for a more dynamic system. Indeed, it might seem unlikely
that thioester linkages could be maintained long enough to allow
development of a polyUb chain (canonically, a K48-linked ubiquitin
tetramer or longer (Thrower et al., 2000)) targeting for degradation.
However, the ﬁrst evidence for poly-ubiquitylation via thioester
linkages to cysteines came from viral E3 ligase systems (Cadwell
and Coscoy, 2005, 2008). A cysteine residue was identiﬁed as a
potential acceptor of Ub in one form of major histocompatibility
complex (MHC) I whereas a form of the protein with a serine at the
same position was  not ubiquitylated (Cadwell and Coscoy, 2005).
Introduction of cysteines to additional positions could also target
for ubiquitylation leading to lysozomal degradation (Cadwell and
Coscoy, 2008). The authors speculated that E3 ligases, such as the
modulators of immune recognition (MIR) E3 ligases which ubiqui-
tylate MHC  I, may  broaden their range of substrates through the
ability to ubiquitylate on non-canonical sites (Cadwell and Coscoy,
2005).
Cysteine ubiquitylation has thus been demonstrated as capable
of targeting cellular proteins for proteasomal-mediated degra-
dation in vertebrate systems. However, such observations are
hampered by the fact that cysteine ubiquitylation is more difﬁ-
cult to identify than ubiquitylation of amine groups chieﬂy, due
to the relative instability of the thioester bond particularly in
ine.
le features References
minus necessary and sufﬁcient for
itylation targeting for degradation
Breitschopf, Bengal (1998)
t evidence from mass spectrometry Coulombe, Rodier (2004)
Bloom et al. (2003), Coulombe,
Rodier  (2004)
Reinstein et al. (2000)
Aviel et al. (2000)
Ikeda et al. (2002)
Fajerman et al. (2004)
ines in human p14ARF; only one lysine in
e  p19ARF with no effect on ubiquitylation
Kuo,  den Besten (2004)
ubiquitylation required for translocation Carvalho, Pinto (2007)
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itylation required
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ass spectrometry analysis (Tait et al., 2007) or under the reduc-
ng conditions of SDS-PAGE. Instead, it is important to adopt a
iochemical approach that takes into account the possibility of
hese more labile ubiquitylation events. For instance, biochemi-
al analysis has been undertaken to investigate the degradation
f the proneural transcription factor Ngn2 using Xenopus frog egg
xtract, which contains all the components required for rapid
PS-mediated degradation of this protein (Vosper et al., 2009).
ild-type Ngn2 is ubiquitylated on cysteines as well as lysines and
he N-terminus. While cysteine ubiquitylation alone is sufﬁcient to
arget for UPS-mediated degradation, mutation of cysteines to ala-
ines in an otherwise wild-type protein has no effect on stability of
gn2 in interphase egg extract. However, mutation of cysteines
lone conferred as much stabilization as mutation of all lysines
o arginines in mitotic extract, indicating a cell cycle-regulated
ole for non-canonical ubiquitylation in this case. The half-life of
gn2 is signiﬁcantly shorter in mitosis than in interphase, and
ysteine ubiquitylation may  contribute to this enhanced rate of
urnover (Vosper et al., 2009). Similar ubiquitylation of Ngn2 via
hioester linkages to cysteines were also seen in the Mus muscu-
us P19 embryonal carcinoma cell line, which responds to Ngn2
ver-expression by undergoing neuronal differentiation, indicating
hat this mode of ubiquitylation is conserved between vertebrate
pecies (McDowell et al., 2010). Moreover, the related proneural
rotein Ngn3 can also be ubiquitylated on cysteines (Roark et al.,
012).
. Hydroxyester linkages to serines, threonines, tyrosines
Ubiquitins could also be attached to serines, threonines and
yrosines via hydroxyester linkages which are more thermody-
amically stable than thioester bonds but form less easily, and
o are conversely less kinetically stable (see Section 8). Evidence
or Ub–hydroxyester linkages is suggested for the protein Bid, pro-
uced as part of the apoptotic pathway (Tait et al., 2007). However,
n this study structural properties such as folding stability (as dis-
inct from non-canonical ubiquitylation) could not be ruled out
s targeting Bid for degradation, due to extensive mutation of the
rotein.
The strongest evidence for Ub–hydroxyester linkages comes
rom research into the endoplasmic reticulum-associated degrada-
ion (ERAD) pathway, where serines and threonines are sufﬁcient
or ubiquitylation of major histocompatibility complex I heavy
hain by the viral E3 ligase mK3  targeting for ERAD (Wang et al.,
007). In this case lysines are also present in the cytoplasmic tail
f the heavy chain but mutation of all lysines and cysteines to
rginines and alanines has no effect on stability; however muta-
ion of serines and threonines to alanines is stabilizing. Moreover,
n absolute requirement for serine residues in targeting a protein
or ERAD was demonstrated in TCR. The cytoplasmic tail of TCR
onsists of the residues RLWSS and is not only ubiquitylated and
egraded but replacement of serines with alanines reduces this
biquitylation, while mutation of serines to cysteines, threonines
r lysines maintains ubiquitylation and degradation (Ishikura et al.,
010). In this case, the exact position of the serines within the
ail is not as important as the nature of the surrounding residues,
here less hydrophobic residues enhance ubiquitylation on ser-
ne.
Non-canonical ubiquitylation for ERAD is upregulated in many
iral infection settings. The HIV protein Vpu interacts with the
CFˇ-TRCP E3 ligase to promote ubiquitylation of BST-2 on cys-
eines, serines and threonines (Tokarev et al., 2011). BST-2 acts
s a regulator of immunity and so targeting it for rapid degra-
ation is advantageous to the survival of the HIV virus. Vpu
as a similar role in targeting CD4 for ERAD (Magadan et al.,iochemistry & Cell Biology 45 (2013) 1833– 1842
2010).  High pH-dependent ubiquitylation was also observed on the
immunoglobulin protein NS-1 but mutation of serines and thre-
onines did not ablate ubiquitylation, which still occurred on lysine
residues (Shimizu et al., 2010). These examples again illustrate the
wide range of viral non-canonical ubiquitylation.
In targeting for proteasomal degradation, serines and threonines
are also implicated in the degradation of the proneural protein
Ngn2 (Vosper et al., 2009). A form of the protein where the N-
terminal amine group is blocked by acetylation, and all lysines
and cysteines are mutated to non-functional replacements, is still
ubiquitylated in Xenopus egg extract and is still stabilized in the
presence of proteasome inhibitors. It is, perhaps, interesting to
compare Ngn2 to the related protein, Ngn3, a transcription factor
also implicated in the regulation of cell cycle exit (Johansson et al.,
2007) but instead best known for its role in directing endocrine cell
fate in the gut and developing pancreas (Bertrand et al., 2002; Gu
et al., 2002; Jenny et al., 2002; Schwitzgebel et al., 2000). Biochem-
ical approaches indicate that, similar to Ngn2, Ngn3 undergoes
non-canonical ubiquitylation. However, mutation of cysteines to
alanines has no effect on the stability of Ngn3 even in a mitotic set-
ting (Roark et al., 2012) whereas Ngn2 is signiﬁcantly stabilized by
mutation of its cysteines to alanines at least in mitosis (McDowell
et al., 2010). In fact there is little evidence that cysteines residues
are ubiquitylated in Ngn3 but instead the evidence points to a role
for serines and threonines, which are clearly ubiquitylated and can
direct destabilization of Ngn3 when all lysine residues are mutated
to arginines (Roark et al., 2012). The differences exposed by com-
parison of these closely related proteins highlight the importance
of investigating ubiquitylation and degradation on a protein by
protein basis rather than relying on extrapolation between family
members.
Tyrosines may  offer a ﬁnal potential site of non-canonical
ubiquitylation. However, whilst containing a similar nucleophilic
hydroxyl group to serines and threonines, tyrosines consist of a
phenolic group, which may  be less reactive than the aliphatic ser-
ine and threonine residues. The presence of an aromatic ring in
this residue may  result in delocalization of electron density around
the aromatic system giving a less reactive lone pair of electrons
on the hydroxyl group. As yet, no direct evidence for tyrosines as
non-canonical sites of ubiquitylation has been demonstrated.
7.  Deubiquitylation
Deubiquitylating enzymes (DUBs) catalyze the removal of ubi-
quitin moieties from proteins, nd use nucleophilic cysteine residues
to attack the carbonyl group of the protein–ubiquitin linkage to lib-
erate the substrate protein, leaving the ubiquitin moiety attached
to the DUB (Amerik and Hochstrasser, 2004). Deubiquitylation can
be used to cancel ubiquitylation signals, as a quality control for
regulating ubiquitylation, and to remove ubiquitin chains from sub-
strate proteins prior to proteasomal degradation. At present there is
no evidence for a role of DUBs in deubiquitylation of non-canonical
residues. DUBs rely on nucleophilic cysteines themselves and, as
discussed below, the exchange of ubiquitin moieties to and from
cysteine residue to cysteine residue in both ubiquitylation and deu-
biquitylation is likely to be a very rapid exchange process that could
provide an extremely dynamic ubiquitylation response.
The  possibility also exists that deubiquitylation could occur
through other channels. Cysteines are very sensitive to the redox
environment of a cell (Wang et al., 2012) and ubiquitylated serineshydrolysis. It is possible that non-enzymatic deubiquitylation could
occur depending on the local environment of the residue such as
its pKa as determined by local protein structure and its subcellular
location. However, this remains to be explored.
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Fig. 3. Extent of orbital overlap in linkages to ubiquitin. In an ester-like linkage between the amino acid residue and the C-terminus of ubiquitin, the extent of orbital overlap
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relates to the size, symmetry and energy of the orbitals involved, how closely the
itrogen are the strongest and thioester linkages using sulfur are the weakest.
. Perspectives: why  does non-canonical ubiquitylation
ccur?
The current evidence for non-canonical ubiquitylation is
ummarized in Table 1. Having established that non-canonical
biquitylation can occur, the question remains as to its physio-
ogical importance. As illustrated in Fig. 3, thioester linkages to
ysteine are actually the weakest bonds a protein could form with
b (Clayden et al., 2000), while ester linkages with hydroxyls
ave an intermediate stability and isopeptide or amide bonds
ith amines form the most stable linkages. Whilst an unstable
ink is perhaps useful in a highly dynamic signaling system, are
Energy
N lone pair 
ig. 4. Kinetics of protein–ubiquitin covalent bond formation. As a soft, high-energy nuc
owest unoccupied molecular orbital (LUMO) of the E2–ubiquitin linkage, which is a soft 
eaction with a sulfur nucleophile will occur more swiftly than with nitrogen.perties match, and whether the bond is polarized. Hence amide bonds involving
cysteines  not simply too weak to be relevant as a nucleophile for
ubiquitylation? In terms of thermodynamics, cysteines indeed
would be a poor choice for stable ubiquitylation. However, the
biochemical environment of the cell rarely ventures into the realm
of stable thermodynamic equilibrium; rather, such biochemical
reactions are governed by the kinetics of reactions.
Fig. 4 illustrates why cysteines may  play a signiﬁcant role par-
ticularly in ubiquitin modiﬁcation for signaling. Ub  is shuttled
along the ubiquitylation cascade from an Ub-activating enzyme,
or E1, to an Ub-conjugating enzyme, or E2, and in the case of HECT
domains, onto an E3 ligase, and in all these cases, Ub is conjugated
to a cysteine residue on the enzyme. Therefore a weak thioester
Thioester carbonyl S lone pair
π
π*
leophile, the lone pair of electrons on sulfur form a better energy overlap with the
electrophile, than the hard nucleophile presented by the nitrogen lone pair. Hence
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inkage is always attacked by a nucleophilic group when ubiquity-
ating a substrate protein. As this thioester link consists of diffuse
rbitals, particularly from the large sulfur atom, and there is not
 large polarization of charge, this is classed as a soft electrophile
Clayden et al., 2000). Soft electrophiles react preferentially with
ucleophiles which are also soft, that is with diffuse large orbitals
nd high energy highest occupied molecular orbitals (HOMOs)
hat overlap well with the lowest unoccupied molecular orbital
LUMOs) of the thioester linkage (which is the carbonyl * MO).
n this respect, sulfur thiols will undergo the fastest reaction with
 thioester carbonyl, followed by hydroxyls, followed by amines,
hich become harder, more charge-dominated nucleophiles. So
hilst an Ub–cysteine linkage may  be labile, it is formed more
uickly than the more stable isopeptide bond and could poten-
ially provide a greater range for dynamic signaling behavior by
biquitylation.
If a variety of different sites in a protein could target for UPS-
ediated degradation, this could provide a highly dynamic system
or swift ubiquitylation and deubiquitylation events. Such a sys-
em may  be required to maintain short-lived proteins in a dynamic
ange of concentrations that can be rapidly altered in response
o changing environmental and developmental cues. A variety of
ifferent ubiquitylating systems could also be employed in rapid
ignaling events or where a labile response is required.
.  Non-canonical ubiquitylation: future prospects
The evidence for non-canonical ubiquitylation is easily missed
y current methods used to investigate ubiquitin-mediated proteo-
ysis due to the similarity in the chemistry of the N-terminal amine
roup to lysine, or the labile nature of thioester and hydroxyester
inkages. Indeed, ubiquitylation assays using both reducing and
on-reducing gel conditions highlight how simple it can be to over-
ook non-canonical ubiquitylation by typical SDS-PAGE methods
McDowell et al., 2010; Vosper et al., 2009). Moreover, mass spec-
rometry provides the most accurate method of directly observing
ost-translational modiﬁcations on proteins but is not ideally
uited to detecting these non-canonical modiﬁcations. Firstly, sta-
istical analyses of spectra must be sophisticated enough to be
ble to identify post-translational modiﬁcation such as ubiquity-
ation (for a review, see Serang and Noble, 2012). Secondly, even
hen ubiquitylation is speciﬁcally investigated, problems with efﬁ-
ient protein digestion, chemical artifacts in sample preparation
nd enrichment strategies using either anti-ubiquitin or anti-
iglycine antibodies (for pre- or post-trypsin digestion enrichment,
espectively) can hinder efﬁcient identiﬁcation, and especially
uantitation, of ubiquitylation events (reviewed in further detail
y Sylvestersen et al., 2013 and discussed in particular refer-
nce to human disease by Kessler, 2013). Finally, even taking
nto account all these other challenges, ubiquitylation on non-
anonical sites, particularly cysteines, serines and threonines, will
ot be observed using regular sample preparation methods due to
igh-temperature and reducing agent-dependent sample prepara-
ion. It is possible that a method determined for palmitoylation
o selectively cap all free cysteines and selectively cleave only
hose with a thioester modiﬁcation could be used (Drisdel and
reen, 2004; Roth et al., 2006) but this will of course be unable
o differentiate between ubiquitylation, palmitoylation and other
hioester modiﬁcations (Tom and Martin, 2013). It is important to
e sensitive to the potential presence of non-canonical ubiquity-
ation, which may  be much more widespread than appreciated
t present, as well as to develop new methodology to detect
istinct non-canonical ubiquitylation events if we are to truly
nderstand the emerging complexity of protein regulation by
biquitylation.iochemistry & Cell Biology 45 (2013) 1833– 1842
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